866-997-4948(US-Canada Toll Free)

Global Myocardial Infarction Treatment Market Professional Survey Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 108 Pages

This report studies the global Myocardial Infarction Treatment market status and forecast, categorizes the global Myocardial Infarction Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw.
The global Myocardial Infarction Treatment market is valued at 1360 million US$ in 2017 and will reach 2180 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2018-2025.

The major manufacturers covered in this report
Bayer
Novartis
Daiichi Sankyo
Boehringer Ingelheim
Astrazeneca
Janssen Biotech
Merck
Sanofi
Pfizer

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antiplatelet Agents
Glycoprotein IIb/IIIa Inhibitors
Antithrombotic Agents
Others

By Application, the market can be split into
Hospital
Clinic

The study objectives of this report are:
To analyze and study the global Myocardial Infarction Treatment capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Myocardial Infarction Treatment manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Myocardial Infarction Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Myocardial Infarction Treatment Manufacturers
Myocardial Infarction Treatment Distributors/Traders/Wholesalers
Myocardial Infarction Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors



Regional and country-level analysis of the Myocardial Infarction Treatment market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Myocardial Infarction Treatment Market Professional Survey Report 2018
1 Industry Overview of Myocardial Infarction Treatment
1.1 Definition and Specifications of Myocardial Infarction Treatment
1.1.1 Definition of Myocardial Infarction Treatment
1.1.2 Specifications of Myocardial Infarction Treatment
1.2 Classification of Myocardial Infarction Treatment
1.2.1 Antiplatelet Agents
1.2.2 Glycoprotein IIb/IIIa Inhibitors
1.2.3 Antithrombotic Agents
1.2.4 Others
1.3 Applications of Myocardial Infarction Treatment
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Myocardial Infarction Treatment
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Myocardial Infarction Treatment
2.3 Manufacturing Process Analysis of Myocardial Infarction Treatment
2.4 Industry Chain Structure of Myocardial Infarction Treatment

3 Technical Data and Manufacturing Plants Analysis of Myocardial Infarction Treatment
3.1 Capacity and Commercial Production Date of Global Myocardial Infarction Treatment Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Myocardial Infarction Treatment Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Myocardial Infarction Treatment Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Myocardial Infarction Treatment Major Manufacturers in 2017

4 Global Myocardial Infarction Treatment Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Myocardial Infarction Treatment Capacity and Growth Rate Analysis
4.2.2 2017 Myocardial Infarction Treatment Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Myocardial Infarction Treatment Sales and Growth Rate Analysis
4.3.2 2017 Myocardial Infarction Treatment Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Myocardial Infarction Treatment Sales Price
4.4.2 2017 Myocardial Infarction Treatment Sales Price Analysis (Company Segment)

5 Myocardial Infarction Treatment Regional Market Analysis
5.1 North America Myocardial Infarction Treatment Market Analysis
5.1.1 North America Myocardial Infarction Treatment Market Overview
5.1.2 North America 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.1.4 North America 2017 Myocardial Infarction Treatment Market Share Analysis
5.2 Europe Myocardial Infarction Treatment Market Analysis
5.2.1 Europe Myocardial Infarction Treatment Market Overview
5.2.2 Europe 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.2.4 Europe 2017 Myocardial Infarction Treatment Market Share Analysis
5.3 China Myocardial Infarction Treatment Market Analysis
5.3.1 China Myocardial Infarction Treatment Market Overview
5.3.2 China 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.3.4 China 2017 Myocardial Infarction Treatment Market Share Analysis
5.4 Japan Myocardial Infarction Treatment Market Analysis
5.4.1 Japan Myocardial Infarction Treatment Market Overview
5.4.2 Japan 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.4.4 Japan 2017 Myocardial Infarction Treatment Market Share Analysis
5.5 Southeast Asia Myocardial Infarction Treatment Market Analysis
5.5.1 Southeast Asia Myocardial Infarction Treatment Market Overview
5.5.2 Southeast Asia 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.5.4 Southeast Asia 2017 Myocardial Infarction Treatment Market Share Analysis
5.6 India Myocardial Infarction Treatment Market Analysis
5.6.1 India Myocardial Infarction Treatment Market Overview
5.6.2 India 2013-2018E Myocardial Infarction Treatment Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Myocardial Infarction Treatment Sales Price Analysis
5.6.4 India 2017 Myocardial Infarction Treatment Market Share Analysis

6 Global 2013-2018E Myocardial Infarction Treatment Segment Market Analysis (by Type)
6.1 Global 2013-2018E Myocardial Infarction Treatment Sales by Type
6.2 Different Types of Myocardial Infarction Treatment Product Interview Price Analysis
6.3 Different Types of Myocardial Infarction Treatment Product Driving Factors Analysis
6.3.1 Antiplatelet Agents Growth Driving Factor Analysis
6.3.2 Glycoprotein IIb/IIIa Inhibitors Growth Driving Factor Analysis
6.3.3 Antithrombotic Agents Growth Driving Factor Analysis
6.3.4 Others Growth Driving Factor Analysis

7 Global 2013-2018E Myocardial Infarction Treatment Segment Market Analysis (by Application)
7.1 Global 2013-2018E Myocardial Infarction Treatment Consumption by Application
7.2 Different Application of Myocardial Infarction Treatment Product Interview Price Analysis
7.3 Different Application of Myocardial Infarction Treatment Product Driving Factors Analysis
7.3.1 Hospital of Myocardial Infarction Treatment Growth Driving Factor Analysis
7.3.2 Clinic of Myocardial Infarction Treatment Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Myocardial Infarction Treatment
8.1 Bayer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Bayer 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bayer 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.3 Daiichi Sankyo
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Daiichi Sankyo 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Daiichi Sankyo 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.4 Boehringer Ingelheim
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Boehringer Ingelheim 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Boehringer Ingelheim 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.5 Astrazeneca
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Astrazeneca 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Astrazeneca 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.6 Janssen Biotech
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Janssen Biotech 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Janssen Biotech 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.7 Merck
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Merck 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Merck 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.8 Sanofi
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Sanofi 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sanofi 2017 Myocardial Infarction Treatment Business Region Distribution Analysis
8.9 Pfizer
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Pfizer 2017 Myocardial Infarction Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Pfizer 2017 Myocardial Infarction Treatment Business Region Distribution Analysis

9 Development Trend of Analysis of Myocardial Infarction Treatment Market
9.1 Global Myocardial Infarction Treatment Market Trend Analysis
9.1.1 Global 2018-2025 Myocardial Infarction Treatment Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Myocardial Infarction Treatment Sales Price Forecast
9.2 Myocardial Infarction Treatment Regional Market Trend
9.2.1 North America 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.2.2 Europe 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.2.3 China 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.2.4 Japan 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.2.6 India 2018-2025 Myocardial Infarction Treatment Consumption Forecast
9.3 Myocardial Infarction Treatment Market Trend (Product Type)
9.4 Myocardial Infarction Treatment Market Trend (Application)

10 Myocardial Infarction Treatment Marketing Type Analysis
10.1 Myocardial Infarction Treatment Regional Marketing Type Analysis
10.2 Myocardial Infarction Treatment International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Myocardial Infarction Treatment by Region
10.4 Myocardial Infarction Treatment Supply Chain Analysis

11 Consumers Analysis of Myocardial Infarction Treatment
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Myocardial Infarction Treatment Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures
Figure Picture of Myocardial Infarction Treatment
Table Product Specifications of Myocardial Infarction Treatment
Table Classification of Myocardial Infarction Treatment
Figure Global Production Market Share of Myocardial Infarction Treatment by Type in 2017
Figure Antiplatelet Agents Picture
Table Major Manufacturers of Antiplatelet Agents
Figure Glycoprotein IIb/IIIa Inhibitors Picture
Table Major Manufacturers of Glycoprotein IIb/IIIa Inhibitors
Figure Antithrombotic Agents Picture
Table Major Manufacturers of Antithrombotic Agents
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Myocardial Infarction Treatment
Figure Global Consumption Volume Market Share of Myocardial Infarction Treatment by Application in 2017
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Market Share of Myocardial Infarction Treatment by Regions
Figure North America Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Figure Europe Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Figure China Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Figure Japan Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Figure Southeast Asia Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Figure India Myocardial Infarction Treatment Market Size (Million USD) (2013-2025)
Table Myocardial Infarction Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Myocardial Infarction Treatment in 2017
Figure Manufacturing Process Analysis of Myocardial Infarction Treatment
Figure Industry Chain Structure of Myocardial Infarction Treatment
Table Capacity and Commercial Production Date of Global Myocardial Infarction Treatment Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Myocardial Infarction Treatment Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Myocardial Infarction Treatment Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Myocardial Infarction Treatment Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Myocardial Infarction Treatment 2013-2018E
Figure Global 2013-2018E Myocardial Infarction Treatment Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Myocardial Infarction Treatment Market Size (Value) and Growth Rate
Table 2013-2018E Global Myocardial Infarction Treatment Capacity and Growth Rate
Table 2017 Global Myocardial Infarction Treatment Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Myocardial Infarction Treatment Sales (K Units) and Growth Rate
Table 2017 Global Myocardial Infarction Treatment Sales (K Units) List (Company Segment)
Table 2013-2018E Global Myocardial Infarction Treatment Sales Price (USD/Unit)
Table 2017 Global Myocardial Infarction Treatment Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure North America 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure North America 2017 Myocardial Infarction Treatment Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure Europe 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure Europe 2017 Myocardial Infarction Treatment Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure China 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure China 2017 Myocardial Infarction Treatment Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure Japan 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure Japan 2017 Myocardial Infarction Treatment Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure Southeast Asia 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure Southeast Asia 2017 Myocardial Infarction Treatment Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Myocardial Infarction Treatment 2013-2018E
Figure India 2013-2018E Myocardial Infarction Treatment Sales Price (USD/Unit)
Figure India 2017 Myocardial Infarction Treatment Sales Market Share
Table Global 2013-2018E Myocardial Infarction Treatment Sales (K Units) by Type
Table Different Types Myocardial Infarction Treatment Product Interview Price
Table Global 2013-2018E Myocardial Infarction Treatment Sales (K Units) by Application
Table Different Application Myocardial Infarction Treatment Product Interview Price
Table Bayer Information List
Table Product Overview
Table 2017 Bayer Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer Myocardial Infarction Treatment Business Region Distribution
Table Novartis Information List
Table Product Overview
Table 2017 Novartis Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Novartis Myocardial Infarction Treatment Business Region Distribution
Table Daiichi Sankyo Information List
Table Product Overview
Table 2017 Daiichi Sankyo Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Daiichi Sankyo Myocardial Infarction Treatment Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product Overview
Table 2017 Boehringer Ingelheim Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Myocardial Infarction Treatment Business Region Distribution
Table Astrazeneca Information List
Table Product Overview
Table 2017 Astrazeneca Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Astrazeneca Myocardial Infarction Treatment Business Region Distribution
Table Janssen Biotech Information List
Table Product Overview
Table 2017 Janssen Biotech Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Janssen Biotech Myocardial Infarction Treatment Business Region Distribution
Table Merck Information List
Table Product Overview
Table 2017 Merck Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Merck Myocardial Infarction Treatment Business Region Distribution
Table Sanofi Information List
Table Product Overview
Table 2017 Sanofi Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi Myocardial Infarction Treatment Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Myocardial Infarction Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Myocardial Infarction Treatment Business Region Distribution
Figure Global 2018-2025 Myocardial Infarction Treatment Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Myocardial Infarction Treatment Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Myocardial Infarction Treatment Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Myocardial Infarction Treatment Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Myocardial Infarction Treatment by Type 2018-2025
Table Global Consumption Volume (K Units) of Myocardial Infarction Treatment by Application 2018-2025
Table Traders or Distributors with Contact Information of Myocardial Infarction Treatment by Region

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *